HDAC Inhibition Induces Patient-Specific Phenotypic Remodeling in Glioblastoma Organoids
This study demonstrates that patient-derived glioblastoma organoids exhibit distinct, patient-specific phenotypic responses to HDAC inhibition, highlighting their utility as translational platforms for evaluating individualized epigenetic therapies.